Skip to main content

Site notifications

Australian Public Assessment Reports (AusPAR)

Search our AusPAR dataset for information on the evaluation of prescription medicines.

Use the filters below to narrow your search.

Filter results

You can narrow down the results using the filters.

Sponsor

An AusPAR provides information about the evaluation of a prescription medicine and the considerations that led the TGA to approve or not approve an application.

For more information see Australian Public Assessment Reports for prescription medicines (AusPARs).

Search

1129 result(s) found, displaying 501 to 525
  • Australian public assessment report for Peramivir
  • Australian Public Assessment Report for Pembrolizumab
  • Australian Public Assessment Report for Guselkumab
  • Australian Public Assessment Report for Panobinostat lactate
  • Australian Public Assessment Report for Crizotinib
  • Australian Public Assessment Report for Cabozantinib
  • Australian Public Assessment Report for Bezlotoxumab
  • Australian Public Assessment Report
  • Australian Public Assessment Report for Alirocumab
  • Australian Public Assessment Report for Fosfomycin trometamol
  • Australian Public Assessment Report for pegaspargase
  • Australian Public Assessment Report for Leuprorelin
  • Australian Public Assessment Report for Etanercept
  • Australian Public Assessment Report for Nadroparin
  • Australian Public Assessment Report for Atezolizumab
  • Australian Public Assessment Report for Migalastat
  • Australian Public Assessment Report for Rituximab
  • Australian Public Assessment Report for Carbetocin
  • Australian Public Assessment Report for Ocrelizumab